John Treace - Mar 4, 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John Treace
Stock symbol
TMCI
Transactions as of
Mar 4, 2025
Transactions value $
$524,064
Form type
4
Date filed
3/4/2025, 06:30 PM
Previous filing
Jan 24, 2025
Next filing
Mar 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Purchase $524K +60K +0.89% $8.73 6.8M Mar 4, 2025 Direct F1, F2
holding TMCI Common Stock 1.61M Mar 4, 2025 By spouse F3
holding TMCI Common Stock 1.47M Mar 4, 2025 by spouse as trustee of a trust F3
holding TMCI Common Stock 1.84M Mar 4, 2025 As trustee of a trust F4
holding TMCI Common Stock 409K Mar 4, 2025 As co-trustee of a trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $8.3150 to $8.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F2 Includes 437,536 restricted stock units
F3 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F4 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.